Merck ' s Lung Cancer Drug Combo Fails Trial Merck ' s Lung Cancer Drug Combo Fails Trial

Merck said on Thursday a combination treatment testing a new type of immunotherapy failed to significantly slow disease progression in lung cancer patients who did not respond to previous treatments.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news